Guardant Health, INC Form 4 insider transactions

Director Tariq Musa sold 116 shares of Guardant Health, Inc. on February 20, 2025, at a price of $48.33 per share.

Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. stock and restricted stock units on February 15, 2025.

Director Myrtle S. Potter reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

Meghan V. Joyce, a director at Guardant Health, Inc., executed stock options on February 4, 2025.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the acquisition and disposal of common stock related to performance-based restricted stock units.

Michael Bell, CFO of Guardant Health, reports the vesting of performance-based restricted stock units and subsequent stock transactions to cover tax obligations.

Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

A director of Guardant Health, Tariq Musa, sold 116 shares of common stock at a price of $37.58 per share on January 17, 2025.

Director Tariq Musa exercised stock options for 250 shares of Guardant Health common stock on January 15, 2025.

Myrtle S. Potter, a director at Guardant Health, Inc., has reported the vesting of 68 restricted stock units.

Terilyn J. Monroe, Chief People Officer at Guardant Health, reports stock transactions including the vesting of restricted stock units and shares withheld for tax obligations.

Guardant Health's Chief Financial Officer, Michael Bell, executed stock transactions involving the vesting of restricted stock units and the sale of shares to cover tax obligations.

Director Meghan Joyce of Guardant Health, Inc. reported the vesting of 66 restricted stock units on January 4, 2025.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported the acquisition and disposal of company stock and restricted stock units on January 1, 2025.

Guardant Health's Chief Information Officer, Kumud Kalia, executed stock transactions involving the vesting of restricted stock units and the sale of shares to cover tax obligations.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting and disposal of restricted stock units to cover tax obligations.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Guardant Health's Chief Financial Officer, Michael Bell, executed transactions involving common stock and restricted stock units on January 1, 2025.

AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, reported transactions involving the acquisition and disposal of company stock and restricted stock units.

Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., reports transactions involving common stock and restricted stock units.

Director Steve Krognes reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

Tariq Musa, a director at Guardant Health, sold 116 shares of common stock at a price of $34.85 per share on December 18, 2024.

Guardant Health's Chief Legal Officer, John G. Saia, reported the acquisition of 1,020 shares and the disposal of 535 shares to cover tax obligations related to vesting restricted stock units.

Director Myrtle S. Potter of Guardant Health, Inc. reports the vesting of restricted stock units and subsequent disposal of shares.

Guardant Health's Chief Information Officer, Kumud Kalia, reported the vesting of restricted stock units and subsequent tax withholding transactions.

Guardant Health's Chief Commercial Officer, Chris Freeman, reported the acquisition of 1,402 shares and the disposal of 597 shares to cover tax obligations related to vesting restricted stock units.

Craig Eagle, Chief Medical Officer of Guardant Health, reported the acquisition of 1,402 shares and the disposal of 711 shares to cover tax obligations related to vesting restricted stock units.

Guardant Health's Chief Financial Officer, Michael Bell, reported the acquisition and disposal of company stock and restricted stock units on December 15, 2024.

Director Tariq Musa of Guardant Health, Inc. engaged in stock transactions, including the sale of 2,320 shares and the vesting of 250 restricted stock units.